Ardelyx (ARDX) Inventory Average (2022 - 2026)
Ardelyx's (ARDX) quarterly Inventory Average came in at $20.2 million in Q1 2026, down 9.94% YoY from $22.5 million in Q1 2025, and down 5.66% on a QoQ basis from $21.5 million in Q4 2025.
Ardelyx (ARDX) Inventory Average (2022 - 2026) Analysis & Trends
Ardelyx (ARDX) has 5 years of Inventory Average data on file, last reported at $20.2 million in Q1 2026.
- Quarterly Inventory Average fell 9.94% year-over-year to $20.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.2 million (down 9.94% YoY) and the FY2025 annual result came in at $19.5 million, up 15.73% from the prior year.
- Inventory Average slipped to $20.2 million in Q1 2026, from $21.5 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $23.7 million in Q3 2025 to a low of $2.3 million in Q4 2022.
- A 5-year average of $12.5 million and a median of $11.5 million in 2024 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2023 — Inventory Average jumped 362.75% — and 2026, when it decreased 9.94%.
- Tracing ARDX's Inventory Average over 5 years: stood at $2.3 million in 2022, then soared by 362.75% to $10.5 million in 2023, then surged by 55.21% to $16.3 million in 2024, then surged by 31.81% to $21.5 million in 2025, then declined by 5.66% to $20.2 million in 2026.
- The last three Inventory Average figures came in at $20.2 million (Q1 2026), $21.5 million (Q4 2025), and $23.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn | 24.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.30 Mn |
| Mar 31, 2026 | 20.24 Mn |
| Dec 31, 2025 | 21.45 Mn |
| Sep 30, 2025 | 23.72 Mn |
| Jun 30, 2025 | 23.03 Mn |
| Mar 31, 2025 | 22.47 Mn |
| Dec 31, 2024 | 16.28 Mn |
| Sep 30, 2024 | 12.57 Mn |
| Jun 30, 2024 | 11.78 Mn |
| Mar 31, 2024 | 11.13 Mn |
| Dec 31, 2023 | 10.49 Mn |
| Sep 30, 2023 | 8.07 Mn |
| Jun 30, 2023 | 6.22 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 2.89 Mn |
| Jun 30, 2022 | 4.01 Mn |